Israeli biotech company begins trial for cancer immuno-oncology solution

The company’s product, NTX1088, blocks the harmful overexpression of PVR proteins, which occurs in tumors caused by lung, breast, throat and other cancers.

Cancer (Illustrative)

Cancer (Illustrative)

(photo credit: INGIMAGE)

ByZACHY HENNESSEY

NOVEMBER 30, 2022 15:10

RECOMMENDED STORIES

Israel at War - Illustrative image of an Israeli F-35 fighter jet.

Israel's defense industry eyes new partners for next-gen fighter jet by 2028

JULY 30, 2025

Leonardo DiCaprio stands on stage during the opening ceremony and the screening the film "Partir un jour" (Leave One Day) Out of competition at the 78th Cannes Film Festival in Cannes, France, May 13, 2025.

Leonardo DiCaprio to open hotel in Israel

JULY 29, 2025

Child Muhammad Zakariya Ayyoub al-Matouq, who suffers from cerebral palsy, alongside mother and brother.

NYT quietly alters Gaza starvation story to include key details of child's medical condition

JULY 30, 2025

Auschwitz concentration camp, operated by Nazi Germany in occupied Poland during the Holocaust.

California governor candidate calls Auschwitz 'solution for homelessness,' sparks critisism

JULY 27, 2025